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The transcriptional transactivator (Tat) from the human immunodeficiency virus (HIV) does not function efficiently in
Chinese hamster ovary (CHO) cells. Only somatic cell hybrids between CHO and human cells and CHO cells containing
human chromosome 12 (CHO12) support high levels of Tat transactivation. This restriction was mapped to interactions
between Tat and TAR. Recently, human cyclin T1 was found to increase the binding of Tat to TAR and levels of Tat
transactivation in rodent cells. By combining individually with CDK9, cyclin T1 or related cyclins T2a and T2b form distinct
positive transcription elongation factor b (P-TEFb) complexes. In this report, we found that of these three cyclins, only cyclin
T1 is encoded on human chromosome 12 and is responsible for its effects in CHO cells. Moreover, only human cyclin T1, not
mouse cyclin T1 or human cyclins T2a or T2b, supported interactions between Tat and TAR in vitro. Finally, after introducing
appropriate receptors and human cyclin T1 into CHO cells, they became permissive for infection by and replication of HIV.
© 1999 Academic Press
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GINTRODUCTION
The transcriptional transactivator (Tat) is essential for
uman immunodeficiency virus (HIV) replication. Indeed,
IV-1, which lacks the Tat gene, results in little to no
xpression of viral proteins in cells (Dayton et al., 1986;
isher et al., 1986; Huet et al., 1989). Tat is unique among
ranscriptional activators in that it interacts with an RNA
tructure rather than a DNA sequence. Interactions be-
ween Tat and the 59 bulge in the transactivation re-
ponse element (TAR) RNA have been studied exten-
ively in vitro. However, the central loop in TAR is also
equired for Tat transactivation in vivo. The simplest
odel that reconciles these findings requires that Tat
nd a cellular protein bind to the 59 bulge and central
oop in TAR, respectively. In this scenario, the loop-
inding protein would also be the transcriptional coacti-
ator of Tat.
Some of the evidence for this model came from stud-
es in rodent cells. Tat functions poorly in mouse (NIH-
T3) and hamster (CHO) cells. However, in rodent–hu-
an somatic cell hybrids and in rodent cells, which
dditionally contain human chromosome 12 (MHC915
nd CHO12), levels of Tat transactivation approach those
bserved in human cells (Hart et al., 1989; Newstein et
l., 1990). Further dissection of this phenotype revealed
hat the primary defect in rodent cells was of tethering
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182at to TAR and that the central loop in TAR was dispens-
ble for low levels of transactivation observed in these
ells (Alonso et al., 1994, 1992; Hart et al., 1995; Jones
nd Peterlin, 1994). This finding suggested the existence
f a cellular Tat cofactor encoded on human chromo-
ome 12, which can bind to the central loop in TAR (Hart
t al., 1995). These initial observations were validated
ith the identification of human cyclin T1 as a Tat cofac-
or (Wei et al., 1998). Cyclin T1 and the cyclin-dependent
inase 9 (CDK9) form the positive transcription elonga-
ion factor b (P-TEFb), which is required for Tat transac-
ivation (Peng et al., 1998). Not only did this human cyclin
1 increase the binding of Tat to TAR in vitro but also its
ntroduction into rodent cells led to higher levels of Tat
ransactivation (Wei et al., 1998). Although cyclin T1 had
een mapped to human chromosome 12, these studies
id not exclude the existence of other proteins that might
lay subservient roles. With the identification of cyclins
2a and T2b, which also form different P-TEFb com-
lexes (Peng et al., 1998), their contributions to HIV
ranscription must be investigated.
Finally, the issue of whether rodent cells can be made
ermissive for HIV replication has assumed some impor-
ance. The development of a small animal model of HIV
eplication and possibly AIDS would aid greatly in the
evelopment of new antiretroviral approaches, including
he development of an anti-HIV vaccine. However, many
ther blocks to HIV replication in rodent cells could exist;
ag, Rev, Vif, and Vpr have all been reported to require
uman coactivators (Braaten et al., 1996; Simon et al.,
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183Tat AND TAR INTERACTIONS AND HIV REPLICATION998; Stivahtis et al., 1997; Winslow and Trono, 1993). To
ddress some of these issues, we first determined that
yclins T2a and T2b are not encoded on human chromo-
ome 12 and that they play no role in Tat transactivation.
econd, we found that cyclin T1 is the only C-type cyclin
hat mediates effects of Tat. Third, the rodent cyclin T1
id not support interactions between Tat and TAR. Fi-
ally, the expression of human cyclin T1 and viral recep-
ors was sufficient for HIV replication in CHO cells.
RESULTS
yclin T1, but not cyclins T2a or T2b, are encoded on
uman chromosome 12
The P-TEFb complex has been implicated strongly in
at transactivation (Mancebo et al., 1997; Zhu et al.,
997). P-TEFb is composed of CDK9 and one of three
yclins (T1, T2a, or T2b) encoded by two genes (Peng et
l., 1998). In HeLa cells, 80% of P-TEFb contains cyclin T1
nd 20% contains either cyclin T2a or T2b (Peng et al.,
998). Human chromosome 12 that encodes cyclin T1
as been demonstrated to increase Tat transactivation in
odent cells (Hart et al., 1989). The chromosomal location
f the gene encoding cyclins T2a and T2b and the role of
hese two cyclins in Tat transactivation are not known.
To determine whether cyclins T2a and T2b could res-
ue Tat transactivation in rodent cells, we first examined
hether their genes were also located on human chro-
osome 12. cDNA fragments from cyclins T1, T2a, and
2b were used to probe Southern blots of digested
enomic DNA from CHO and CHO12 cells (Fig. 1). DNA
rom human 293T kidney cells served as the positive
ontrol. The positions and lengths of DNA probes are
resented below the Southern blots, which also reveal
he region of identity between cyclins T2a and T2b. Only
yclin T1 is present on human chromosome 12 (Fig. 1,
op, lanes 2 and 3). The intensity of the cyclin T1 band in
HO12 cells is about one half that in 293T cells, which is
ompatible with the presence of only one human chro-
osome 12 in CHO12 cells. From these data, we con-
lude that only cyclin T1 is encoded on human chromo-
ome 12 and is present in CHO12 cells. On the other
and, cyclins T2a and T2b hybridize to two fragments of
he same molecular mass only in 293T cells (Fig.1, cyclin
2a and T2b panels). Thus cyclins T2a and T2b are
ncoded on a different human chromosome and are not
resent in CHO12 cells.
uman cyclin T1 rescues Tat transactivation in CHO
ells
Although human cyclin T1 can increase Tat transac-
ivation in rodent cells, it might not be the only cofactor
f Tat encoded on human chromosome 12; additional
enes could contribute to Tat transactivation in CHO12
ells. To address this issue directly, we cotransfected 2lasmids containing human cyclin T1, Tat, and HIV-1
ong terminal repeat (LTR) linked to the CAT reporter
ene into CHO and CHO12 cells. If cyclin T1 was
olely responsible for human chromosome 12 pheno-
ype, then increasing amounts of exogenous human
yclin T1 over that expressed from human chromo-
ome 12 should have little to no effect on Tat transac-
ivation. In addition, the expression of only human
yclin T1 was expected to achieve levels of transacti-
ation in CHO cells that equal those observed in
HO12 cells.
Indeed, increasing amounts of human cyclin T1 in-
reased the activity of Tat only 2-fold in CHO12 cells
Fig. 2, bottom). In these cells, Tat transactivation rose
rom 45- to 90-fold (Fig. 2, top). In sharp contrast, cyclin
1 increased levels of Tat transactivation up to 8-fold
ver those observed with Tat alone in CHO cells (Fig.
FIG. 1. Cyclin T1, but not cyclins T2a and T2b, is encoded on human
hromosome 12. Presented are Southern blots of genomic DNA from
HO, CHO12, and 293T cells cut with HindIII and hybridized under
tringent conditions with fluorescein-labeled cDNA probes to human
yclin T1, T2a, and T2b. The regions from cDNAs used as DNA probes
re diagrammed below the Southern blots. Note also the identical
equences shared between cyclins T2a and T2b (gray rectangles).
yclins T2a and T2b differ only C-terminal to residues 642. Lanes in
outhern blots correspond to DNA from CHO, CHO12, and 293T cells., bottom). In these cells, Tat transactivation increased
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184 WIMMER ET AL.rom 8- to 64-fold (Fig. 2, top). A linear dose response
urve was observed over a range of concentrations for
hich ratios of cyclin T1 to Tat varied from 1 to 10 (Fig.
). At higher concentrations of cyclin T1, a plateau was
eached, and ultimately decreased levels of Tat trans-
ctivation were observed (data not presented). A sim-
lar observation was reported previously for NIH-3T3
ells and probably represents an imbalance of pro-
eins that make up P-TEFb (Wei et al., 1998). Impor-
antly, the optimal concentration of cyclin T1 was de-
ermined to be at a 10-fold excess over Tat, where
bsolute levels of Tat transactivation were similar be-
ween CHO and CHO12 cells (Figs. 2 and 3B). We
onclude that human cyclin T1 rescues Tat transacti-
ation in CHO cells and is the only relevant cofactor
FIG. 2. Human cyclin T1 increases Tat transactivation in CHO cells.
otransfections of plasmids encoding Tat and HIV-1 LTR linked to the
AT reporter gene resulted in 8- and 45-fold transactivation in CHO and
HO12 cells, respectively. CAT activities obtained with Tat and TatZX,
hich contains a missense mutation in Tat (Cujec et al., 1997), were
ompared (top). On the addition of human cyclin T1, up to 8- and 2-fold
igher levels of Tat transactivation were observed in CHO and CHO12
ells, respectively (bottom). In the context of increasing amounts of
yclin T1, plotted are fold-transactivation by Tat (top) and by human
yclin T1 and Tat over that observed with Tat alone (bottom). The
mount of cotransfected Tat plasmid was kept constant at 0.1 mg. Data
re representative of three transfections performed in triplicate with
resented SEM values. Calculations of fold-transactivation by cyclin T1
nd Tat over Tat alone were based on mean values obtained from
ndividual transfections.ncoded on human chromosome 12. cffects of human cyclin T1 are specific, and human
yclins T2a and T2b do not rescue Tat transactivation
n rodent cells
It has been reported that these C-type cyclins can
ncrease the expression from other promoters, such as,
he cytomegalovirus (CMV) immediate-early promoter,
hich also directed the synthesis of Tat in our trans-
ected cells (Peng et al., 1998). Although results in CHO
nd CHO12 cells suggested that effects of cyclin T1 were
pecific, we wanted to prove formally that increased
evels of Tat cannot rescue the rodent defect in CHO
ells. To this end, we cotransfected increasing amounts
f the Tat effector plasmid with pHIVSCAT into CHO and
HO12 cells. As presented in Fig. 3A, increasing
mounts of Tat over 0.1 mg had little to no effect on Tat
ransactivation in CHO and CHO12 cells. Also, under
imilar conditions, cyclin T1 had a ,2-fold effect on the
xpression from the CMV promoter that directed the
xpression of Tat (data not presented). We conclude that
ata from Fig. 2 reflect effects of cyclin T1 and not
onspecific effects of increased activity of P-TEFb on
ranscription in general.
Having established optimal ratios between cyclin T1
nd Tat for Tat transactivation in CHO and CHO12 cells
nd having demonstrated that these effects were spe-
ific, we wanted to determine next whether cyclins T2a
nd T2b also contributed to the function of Tat in rodent
ells. However, as presented in Fig. 3B, only cyclin T1,
ut not cyclins T2a or T2b, rescued Tat transactivation in
HO cells. Neither of these two related cyclins had any
ppreciable effect in CHO12 cells (Fig. 3B). Additionally,
oexpression of Tat and both cyclins T2a and T2b in the
ame cells had no effect (data not presented). Thus not
nly is cyclin T1 alone encoded on human chromosome
2 but also human cyclin T1 is solely responsible for
escuing the rodent defect in Tat transactivation.
nly human cyclin T1 supports interactions between
at and TAR in vitro
To test the prediction from genetic studies that the
odent cyclin T1 should not support interactions between
at and TAR, we performed electrophoretic mobility shift
ssays with radiolabeled TAR and relevant proteins ex-
ressed in Escherichia coli or coupled in vitro transcrip-
ion and translation system using the rabbit reticulocyte
ysate. Additionally, we wanted to know whether cyclins
2a and T2b could interact with Tat and TAR in vitro. As
resented in Fig. 4, only the addition of human cyclin T1
o Tat and TAR led to a strong retarded band (lane 2). This
inding required the central loop (Fig. 4, lane 4) and the
9 bulge in TAR (data not presented). Importantly, neither
odent cyclin T1 (Fig. 4, lane 6) nor human cyclins T2a
Fig. 4, lane 10) and T2b (Fig. 4, lane 14) supported
nteractions between Tat and TAR in vitro. Under the
onditions of our assay, Tat alone did not bind to TAR
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185Tat AND TAR INTERACTIONS AND HIV REPLICATIONFig. 4, lanes 6, 10, and 14). Because human cyclin T1
ontributed equally to Tat transactivation in both mouse
nd hamster cells (Wei et al., 1998), we used the mouse
FIG. 3. Increasing amounts of Tat and the coexpression of cyclins
mounts of Tat expressed in CHO and CHO12 cells do not increase leve
iven under the bar graph), Tat transactivation remains constant in CH
ndependent transfections. (B) Only human cyclin T1, but not cyclins T
hich were determined for cyclin T1 (Fig. 2), only cyclin T1 increased T
ells. Cyclins T2a and T2b had no effect. Data are representative of two
FIG. 4. Human cyclin T1 supports interactions between Tat and TAR in
itro. Human cyclins T1, T2a, and T2b and the mouse cyclin T1 were
ncubated with Tat and labeled TAR RNA. Proteins were expressed from E.
oli and coupled in vitro transcription and translation systems using the
abbit reticulocyte lysate. Cyclin refers to the addition of various cyclins:
T1 (human cyclin T1), mT1 (mouse cyclin T1), hT2a (human cyclin T2a),
nd hT2b (human cyclin T2b). TAR refers to different TAR structures used:
t (wild type), Dloop (TAR deleted in the central loop). The removal of the
9 bulge gave results identical to those observed with Dloop (data not
resented). Tat refers to the presence (1) and absence (2) of Tat in our
eactions. TAR 1 Tat 1 hT1 indicates the position of the retarded complex
in the presence of TAR, Tat, and human cyclin T1.yclin T1 for these studies. The cloning and sequence of
his mouse cyclin T1 will be reported elsewhere. We
onclude that only human cyclin T1 supports interactions
etween Tat and TAR in vitro and represents the tether-
ng factor for Tat transactivation in vivo.
yclin T1 rescues HIV-1 proviral gene expression in
HO cells
To determine whether this rescue of Tat transactiva-
ion could be extrapolated to increased levels of expres-
ion of viral proteins in CHO cells, we cotransfected
lasmids containing the HIV-1 provirus (HIV-1NL4-3) and
yclin T1 into CHO and CHO12 cells. HIV-1NL4-3 repre-
ents a T cell tropic virus and infects cells that express
D4 and CXCR4 on the surface (Adachi et al., 1986).
hese transfections also addressed the question about
otential rodent blocks to other viral regulatory, acces-
ory, and structural proteins, that is to Gag, Rev, Vif, and
pr (Braaten et al., 1996; Simon et al., 1998; Stivahtis et
l., 1997; Winslow and Trono, 1993). Supernatents of
ransfected cells were harvested 48 h after transfection,
nd amounts of p24 Gag and of infectious viral particles
ere assessed by p24 ELISA and the use of Sx22-1
eporter cells, respectively. Sx22-1 cells are derivative of
eLa cells, which contain the b-galactosidase gene un-
er the control of the HIV-1 LTR (Fackler et al., 1997). As
resented in Fig. 5A, cyclin T1 rescued HIV-1 gene ex-
ression in CHO cells to levels observed in CHO12 cells
T2b do not increase Tat transactivation in CHO cells. (A) Increasing
t transactivation. Over a range of concentrations (0.3–1 mg) of Tat (also
te bars) and CHO12 (black bars) cells. Data are representative of two
2b, increase transactivation in CHO cells. At optimal concentrations,
activation 8-fold in CHO (white bars) and 2-fold in CHO12 (black bars)
ndent transfections performed in triplicate with presented SEM values.T2a or
ls of Ta
O (whi
2a or Tn a dose-dependent manner. Moreover, viral particles
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186 WIMMER ET AL.roduced by CHO12 cells or by CHO cells expressing
uman cyclin T1 were fully competent to infect human
x22-1 cells (Fig. 5B). We conclude that the lack of
uman cyclin T1 represents the major impediment to the
xpression of viral genes from the HIV provirus in CHO
ells and that reported blocks to other viral proteins and
irion assembly play minor roles.
he addition of human CD4 and chemokine receptors
o cyclin T1 renders CHO cells fully competent for
IV infection and replication
Having established that proviral replication was re-
tored in CHO cells expressing human cyclin T1, we
anted to determine next whether there were additional
locks to viral entry and integration in these cells. Thus
e investigated whether the lack of human cyclin T1
epresents the only impediment to the complete replica-
ive cycle of both T cell and macrophage tropic HIV. To
his end, we coexpressed human CD4, CCR5, or CXCR4
eceptors together with cyclin T1 in CHO and CHO12
ells (Fig. 6). As a control for human cells, we also
oexpressed these same receptors in HeLa cells. HeLa
ells were chosen because transfection efficiencies of
eLa and CHO cells by electroporation are comparable.
dditionally, because HeLa cells do not express CD4,
nly transfected cells can be infected by HIV.
After transfection, these cells were cocultured with
urkat cells that were transfected with plasmids that
ontained the complete HIV-1YU-2 or HIV-1NL4-3 provi-
uses. HIV-1YU-2 and HIV-1NL4-3 represent macrophage
nd T cell tropic viruses, respectively (Adachi et al., 1986;
i et al., 1992). They infect cells bearing CD4 and CCR5
nd CD4 and CXCR4, respectively (Berger, 1997). Cocul-
FIG. 5. CHO cells that express human cyclin T1 support HIV replica
24 increase with the expression of increasing amounts of human cycl
ere cotransfected into CHO (white bars) and CHO12 (black bars) cell
f plasmid DNA are given below the bar graphs in micrograms. Data are
resented SEM values. (B) Virions produced by CHO and CHO12 cells
nfect Sx22-1 cells that express CD4 and CXCR4 and contain the HIV
epresent foci of infected cells and can be extrapolated to numbers ofivation rather than direct infection by viral stocks was Tequired due to small numbers of transfected cells bear-
ng appropriate receptors for HIV. After the infection of
HO or HeLa cells, Jurkat cells and free virus were
emoved by extensive washing, and viral replication was
llowed to proceed for 2 additional days in the adherent
ells. Amounts of p24 Gag and infectious virus were
easured as in Fig. 5. No residual virus could be mea-
ured in mock-transfected CHO, CHO12, and HeLa cells
data not presented).
In CHO cells expressing human cyclin T1 and CHO12
ells, levels of p24 that approximated those found in
eLa cells were observed with HIV-1YU-2 (Fig. 5A). In
harp contrast, CHO cells lacking human cyclin T1 did
ot replicate HIV-1YU-2 (Fig. 6A). The same phenotype
as observed with the infectivity assay of HIV-1NL4-3 in
x22-1 cells (Fig. 6B). In this experiment, HeLa cells
roduced slightly .2-fold more infectious HIV-1NL4-3 than
HO12 cells (Fig. 6B). Again, human cyclin T1 rescued
iral replication in CHO cells. From these experiments,
e conclude that human cyclin T1 not only rescues Tat
ransactivation but also that the entire intracellular rep-
icative cycle of HIV. When appropriate human receptors
re also provided, in the presence of human cyclin T1,
IV can infect and replicate in CHO cells to levels that
re similar to those achieved in human cells.
DISCUSSION
In this study, we demonstrated that only human cyclin
1, but not cyclins T2a and T2b, are encoded on human
hromosome 12. Only cyclin T1 rescued the restriction of
at transactivation in CHO cells. Furthermore, only hu-
an cyclin T1, but not rodent cyclin T1 or human cyclins
2a and T2b, supported interactions between Tat and
d the production of infectious virions from proviral DNA. (A) Levels of
CHO cells. Plasmids containing the HIV-1NL4-3 provirus and cyclin T1
days later, levels of p24 were measured in the supernatant. Amounts
entative of three independent experiments performed in triplicate with
fect human indicator Sx22-1 cells. Supernatants from A were used to
linked to the b-galactosidase reporter gene. Numbers of blue cells
us virions. Data are representative of three independent experiments.tion an
in T1 in
s. At 2
repres
can in
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187Tat AND TAR INTERACTIONS AND HIV REPLICATIONentral loop in TAR. Finally, CHO cells expressing human
yclin T1 and appropriate viral receptors became per-
issive for HIV replication.
The effects of human cyclin T1 were not on the general
ranscription of cellular or viral genes. A major caveat to
ur experiments could have been that increased levels
f Tat would by themselves rescue Tat transactivation in
HO cells. However, although increasing amounts of
uman cyclin T1 had a pronounced effect on Tat trans-
ctivation, they did not increase levels of Tat in these
ells. Moreover, increasing the expression of human
yclin T1 had little to no effect on Tat transactivation in
HO12 cells. These data suggest that one copy of hu-
an chromosome 12 provided sufficient levels of human
yclin T1 and that it is the only protein encoded on
uman chromosome 12 that acts as a coactivator of Tat.
ecause cyclins T2a and T2b alone or in combination
ad no effect on Tat transactivation, they form different
-TEFb complexes that are not recruited by Tat to TAR.
hese conclusions were strengthened by binding stud-
es, in which only human cyclin T1 supported interac-
ions between Tat and TAR in vitro. This binding was
pecific and required an intact central loop and 59 bulge
n TAR. Thus genetic studies postulating a defect in the
ethering of Tat to TAR in rodent cells now found a solid
iochemical foundation.
Furthermore, human cyclin T1 rescued viral replication
n CHO cells. Because only few cells were transfected
ith all plasmids and could be targeted by HIV, relatively
ow levels of viral replication were observed in our infec-
ion assays. However, the infectivity of new virions ob-
FIG. 6. Human CD4, CCR5 or CXCR4, and cyclin T1 permit HIV infectio
n human cells. (A) Human cyclin T1 is required in addition to human C
nd HeLa cells were cotransfected with plasmids containing human CD
n the supernatant were measured 2 days later. Human cyclin T1 allow
CR5 (white bars). HeLa (gray bars) cells allow for slightly higher leve
lasmids used are given below the bar graphs. Data are representative
equired and sufficient for the full viral replicative cycle of HIV-1NL4-3, re
ransfected and infected rodent and HeLa cells were transferred to Sx2
resence of human cyclin T1 in CHO cells (white bars), and amounts o
ells (gray bars).ained from human (HeLa) and rodent (CHO) cells was 1imilar. Moreover, the introduction of proviruses and hu-
an cyclin T1 led to the production of high levels of
nfectious HIV from CHO cells in our transient expression
ssays. Again, human and rodent cells were compara-
le. We conclude that apart from the lack of appropriate
eceptors and human cyclin T1, CHO cells are permissive
or the function of other viral structural, regulatory, and
ccessory proteins. Although additional blocks may be
resent in mouse cells, human cyclin T1 will have to be
ncluded in the establishment of any future model of
IDS in the transgenic mouse.
Our study is compatible with the simple model that
ne protein serves as both the RNA-tethering and tran-
criptional coactivator of Tat. This protein is human cy-
lin T1. Thus human cyclin T1 must have surfaces that
ind to Tat and TAR. They might or might not be sepa-
able, and Tat itself provides an additional surface for
nteractions with TAR. In this scenario, Tat binds to the 59
ulge and human cyclin T1 to the central loop in TAR.
ubsequent to the binding to TAR, CDK9, which is in the
-TEFb complex with the cyclin T1, phosphorylates the
-terminal domain of RNA polymerase II. Efficient elon-
ation of viral transcription ensues. In this process, viral
pecific interactions between Tat and human cyclin T1
hould become targets for possible future therapeutic
ntervention.
MATERIALS AND METHODS
ell culture
Jurkat, CHO, and CHO12 cells were grown in RPMI
O cells and viral replication to levels that approximate those observed
d CCR5 for productive HIV-1YU-2 infection of CHO cells. CHO, CHO12,
5, and cyclin T1. They were then infected with HIV-1YU-2. Levels of p24
he replication of HIV-1YU-2 in CHO cells that express human CD4 and
pression of viral proteins than CHO12 cells (blacks bars). Amounts of
independent experiments. (B) Human CD4, CXCR4, and cyclin T1 are
in the production of infectious virions in CHO cells. Supernatants from
icator cells as in Fig. 5B. Infectious virions were observed only in the
ious viruses were 2.5 times lower in CHO12 (black bars) than in HeLan of CH
D4 an
4, CCR
s for t
ls of ex
of two
sulting
2-1 ind
f infect640 supplemented with 10% FCS and antibiotics with
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188 WIMMER ET AL.dditional 4 mM histidinol (CHO12). HeLa, Sx22-1, and
93T cells were grown in DMEM with 10% FCS and
ntibiotics. They were maintained at 37°C and 5% CO2.
outhern blotting
Genomic DNA was extracted from CHO, CHO12, and
93T cells using standard procedures. DNA (10 mg) was
igested with HindIII for 12 h at 37°C and subjected to
lectrophoresis on 0.8% agarose gels. DNA was trans-
erred to Hybond N1 membranes, cross-linked with UV
ight, prehybridized for 1 h and hybridized with 10 ng of
luorescein-labeled DNA probe for 12 h at 65°C following
he protocols supplied by the manufacturer (Amersham,
vanston, IL). Blots were washed twice with 23 SSC,
.1% Triton X-100, and 0.53 SSC, 0.1% Triton X-100, re-
pectively, at 65°C, followed by immunochemical detec-
ion and exposure to ECL film (Amersham). DNA probes
ere obtained by digesting pcDNA3-T1 with PpuMI and
coRI and pcDNA3-T2a as well as pcDNA3-T2b with
puMI and ApaI, respectively (Peng et al., 1998).
AT assays
Cells (CHO and CHO12) were seeded at a density of
06 cells/60-mm dish in RPMI and 10% FCS supple-
ented with antibiotics. After incubation for 48 h, cells
ere transfected with plasmid DNA using Lipofectamine
GIBCO BRL, Gaithersburg, MD). The reporter plasmid
HIVSCAT and the effector plasmid pcDNA3-Tat were
escribed previously (Cujec et al., 1997). All transfections
ere balanced for a total 5 mg of DNA with the empty
cDNA3 plasmid vector. At 48 h after the transfection,
ells were lysed and CAT activities were measured by a
iquid scintillation assay as described previously (Cujec
t al., 1997).
lectrophoretic mobility shift assays
The a-32P-labeled wild-type and mutant TAR RNA spe-
ies were prepared by in vitro transcription of linearized
lasmid templates as described before (Fujinaga et al.,
998). Cyclins were synthesized from a coupled in vitro
ranscription and translation system using the rabbit re-
iculocyte lysate (Promega, WI). Amounts of cyclins were
ormalized by measuring the incorporation of 35S-methi-
nine and cysteine. RNA probes were incubated in bind-
ng buffer [30 mM Tris, pH 8.0, 70 mM KCl, 0.1% Nonidet
-40, 5.5 mM MgCl2, 1 mM DTT, 13% glycerol, 53 mg/ml
oly(dI)/poly(dC), 31 mg/ml poly(I)/poly(C)] with cyclin
roteins (5 ml of the IVT product), in the presence or
bsence of 80 ng of purified Tat protein (Fujinaga et al.,
998) for 10 min at 30°C. The reaction mix was subjected
o nondenaturing polyacrylamide (6%) gel electrophore-
is, and the gel was subsequently dried and analyzed by
utoradiography.roviral transfections
Cells (107 CHO or CHO12) were cotransfected with 3.5
g of pNL4-3 plasmid, which contains the entire
IV-1NL4-3 provirus, and varying amounts of pcDNA3-T1
y electroporation (250 V, 960 mF). The total amount of
NA was kept constant at 30 mg with the addition of
mpty pcDNA3 plasmid vector. At 48 h after the trans-
ection, p24 levels were determined by p24 ELISA in the
upernatant (New England Nuclear, Boston, MA). To de-
ermine amounts of infectious virions produced by CHO
nd CHO12 cells, 500 ml of supernatants from these cells
ere transferred onto Sx22-1 indicator cells (Fackler et
l., 1997), which were seeded at 5 3 104 cells/well in
4-well plates the previous day. After another 36 h, these
ells were stained for b-galactosidase by standard pro-
ocols (Fackler et al., 1997).
iral infection assays
Then, 10 mg of pCD4, pcCCR5, pcFusin, and varying
mounts of pcDNA3-T1 were cotransfected into 107 CHO,
HO12, and HeLa cells by electroporation (as above)
Deng et al., 1996; Peng et al., 1998). At the same time, 30
g of pYU-2 or pNL4-3 plasmid, which contains the
ntire HIV-1YU-2 or HIV-1NL4-3 provirus, were transfected
nto 107 Jurkat cells by electroporation (180 V, 960 mF)
Adachi et al., 1986; Li et al., 1992). After 24 h, transfected
urkat cells were cocultured with target cells and re-
oved 48 h later by extensive washing. Cells were then
rown for additional 48 h, at which time cellular super-
atants were collected and used to determine levels of
24 or to infect Sx22-1 as described above. When Jurkat
ells were cocultured with untransfected CHO and
HO12 cells, no p24 was detected and no infectious
irus was recovered.
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